Back to search

Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.

Data up to Jan 2025

Published1991
Citations33
References24

Total Citations Per Year

Abstract

References (24)

A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

1981 • 565 citations

Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.

1986 • 408 citations

Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.

1984 • 217 citations

Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.

1988 • 210 citations

Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas

1983 • 196 citations

Recombinant Interferon Enhances Monoclonal Antibody-Targeting of Carcinoma Lesions in Vivo

1987 • 178 citations

Monoclonal Antibody B72.3 Reactivity with Human Endometrium

1987 • 128 citations

A radioimmunoassay for the detection of a human tumor‐associated glycoprotein (tag‐72) using monoclonal antibody B72.3

1986 • 110 citations

Clinical applications of carcinoembryonic antigen.

1988 • 95 citations

Selective Interferon-Induced Enhancement of Tumor-Associated Antigens on a Spectrum of Freshly Isolated Human Adenocarcinoma Cells

1989 • 92 citations

Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.

1990 • 91 citations

Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.

1988 • 86 citations

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG‐72)

1986 • 86 citations

Human Biologic Response Modification by Interferon in the Absence of Measurable Serum Concentrations: A Comparative Trial of Subcutaneous and Intravenous Interferon-beta serine

1989 • 74 citations

Ca 72‐4 radioimmunoassay for the detection of the tag‐72 carcinoma‐associated antigen in serum of patients

1989 • 72 citations

Complementation of anti‐CEA and anti‐TAG‐72 monoclonal antibodies in reactivity to human gastric adenocarcinomas

1987 • 52 citations

Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human gamma-interferon.

1989 • 51 citations

Detection of the Tumor-Associated Glycoprotein Antigen (TAG-72) in Premalignant Lesions of the Colon

1989 • 45 citations

Enhancement by gamma-interferon of in vivo tumor radiolocalization by a monoclonal antibody against HLA-DR antigen.

1986 • 35 citations

Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.

1990 • 24 citations

Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.

1990 • 23 citations

Recombinant interferon-γ lacks activity against metastatic colorectal cancer but increases serum levels of ca 19-9

1989 • 22 citations

Criteria for monitoring carcinoembryonic antigen: variability of sequential assays at elevated levels.

1984 • 18 citations

Complementation of Expression of Carcinoembryonic Antigen and Tumor Associated Glycoprotein-72 (TAG-72) in Human Colon Adenocarcinomas

1991 • 6 citations

Cited By (0)

Loading...
Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated… (1991) – PubMed | Metascience Observatory Explorer